Cargando…
Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era
Primary hyperoxaluria type 1 (PH1) is an autosomal recessive inborn error of metabolism characterized by marked hepatic overproduction of oxalate due to deficiency of hepatic peroxisomal alanine-glyoxylate aminotransferase caused by AGXT gene mutation. One major hallmark of PH1 in developed as well...
Autores principales: | Soliman, Neveen A, Mabrouk, Sameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113489/ https://www.ncbi.nlm.nih.gov/pubmed/35592622 http://dx.doi.org/10.1093/ckj/sfab203 |
Ejemplares similares
-
Primary hyperoxaluria type 1: urologic and therapeutic management
por: Kohli, Harjivan, et al.
Publicado: (2022) -
Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022) -
Primary hyperoxaluria type 1: novel therapies at a glance
por: Bacchetta, Justine, et al.
Publicado: (2022) -
Primary hyperoxaluria type 1: pathophysiology and genetics
por: Fargue, Sonia, et al.
Publicado: (2022) -
Primary hyperoxaluria: the pediatric nephrologist's point of view
por: Ben-Shalom, Efrat, et al.
Publicado: (2022)